Completed PHASE2 INTERVENTIONAL 2-arm NCT01567657

Safety Study of Two Regimen for Sedation for Transesophageal Echocardiography

Phase II Study of Comparison of Two Sedation Regimen for Transesophageal Echocardiography in Point of View of Blood Pressure Response, Safety and Patient Comfort

Sponsor: Kantonsspital Münsterlingen

Conditions Hypotension

Interventions Propofol pethidin hydrochlorid, midazolam

Updated 5 times since 2017 Last updated: Jan 25, 2013 Started: Jan 31, 2012 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hypotension, this trial is completed. The trial is conducted by Kantonsspital Münsterlingen and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kantonsspital Münsterlingen

Data source: Kantonsspital Münsterlingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Münsterlingen, Switzerland